Status:
COMPLETED
Primary Hemostasis Pathology in Patients on ECMO During Lung Transplantation
Lead Sponsor:
University Hospital, Motol
Conditions:
ECMO Primary Hemostasis Pathology
Eligibility:
All Genders
18-70 years
Brief Summary
Lung transplantation is a very long and difficult procedure accompanied by a number of possible complications. In the vast majority of cases, the operation itself is performed using the ECMO support, ...
Detailed Description
ECMO is a type of extracorporeal circulation that has experienced a significant increase in use in the last decade as a substitute for lung or heart functions in patients, both perioperatively - espec...
Eligibility Criteria
Inclusion
- All patients undergoing elective bilateral lung transplantation on ECMO
Exclusion
- patients on dual antiplatelets therapy or patients with vWF disease
Key Trial Info
Start Date :
November 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 15 2023
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04456894
Start Date
November 7 2020
End Date
August 15 2023
Last Update
February 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UH Motol
Prague, Česká Republika, Czechia, 150 06